Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Alpha-phenyl-2-piperidineacetic Acid
2. Ritalinic Acid, (r*,r*)-(+-)-isomer
1. 19395-41-6
2. 2-phenyl-2-(piperidin-2-yl)acetic Acid
3. Phenyl(piperidin-2-yl)acetic Acid
4. 2-phenyl-2-piperidin-2-ylacetic Acid
5. Phenyl(2-piperidinyl)acetic Acid
6. 2-phenyl-2-(2-piperidyl)acetic Acid
7. Alpha-phenyl-2-piperidineacetic Acid
8. Alpha-phenylpiperidine-2-acetic Acid
9. Mfcd06200695
10. Dl-threo-ritalinic Acidsee R533110
11. 2-phenyl-2-piperidineacetic Acid
12. 54631-24-2
13. Einecs 243-020-7
14. 2-phenyl-2-(2-piperidyl) Acetic Acid
15. Ritalinic Acid, 99% (cp)
16. Schembl1462581
17. Chebi:83481
18. Dtxsid20864888
19. Ritalinic Acid, Analytical Standard
20. Bcp07811
21. Bcp26035
22. Phenyl(2-piperidinyl)acetic Acid #
23. S5251
24. Akos015892837
25. 2-piperidineacetic Acid, Alpha-phenyl-
26. Ac-8122
27. Cs-w022954
28. Fs-3198
29. 2-phenyl-2-piperidineacetic Acid, 98%
30. Sy030346
31. Db-014888
32. Ft-0653505
33. Ft-0674435
34. Ft-0674438
35. Ft-0674439
36. Ft-0674440
37. Ft-0674441
38. Ft-0674442
39. Ft-0674443
40. R0111
41. A19443
42. 395r416
43. Q17052328
44. Phenyl(2-piperidinyl)acetic Acid;2-phenyl-2-piperidineacetic Acid
45. L-threo-ritalinic Acid;(2s)-2-phenyl-2-[(s)-2-piperidinyl]acetic Acid
1. Dl-threo-ritalinic Acid Hydrochloride
2. 19395-39-2
3. Dl-threo-ritalinic Acid Hcl
4. Ritalinic Acid Hydrochloride
5. D-threo-ritalinic Acid Hcl
| Molecular Weight | 219.28 g/mol |
|---|---|
| Molecular Formula | C13H17NO2 |
| XLogP3 | -2.4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 3 |
| Exact Mass | 219.125928785 g/mol |
| Monoisotopic Mass | 219.125928785 g/mol |
| Topological Polar Surface Area | 49.3 Ų |
| Heavy Atom Count | 16 |
| Formal Charge | 0 |
| Complexity | 236 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Digital Content
NEWS #PharmaBuzz
Market Place
ABOUT THIS PAGE
10
PharmaCompass offers a list of Ritalinic Acid API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ritalinic Acid manufacturer or Ritalinic Acid supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ritalinic Acid manufacturer or Ritalinic Acid supplier.
PharmaCompass also assists you with knowing the Ritalinic Acid API Price utilized in the formulation of products. Ritalinic Acid API Price is not always fixed or binding as the Ritalinic Acid Price is obtained through a variety of data sources. The Ritalinic Acid Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A D-Threo-Ritalinic Acid HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of D-Threo-Ritalinic Acid HCl, including repackagers and relabelers. The FDA regulates D-Threo-Ritalinic Acid HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. D-Threo-Ritalinic Acid HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A D-Threo-Ritalinic Acid HCl supplier is an individual or a company that provides D-Threo-Ritalinic Acid HCl active pharmaceutical ingredient (API) or D-Threo-Ritalinic Acid HCl finished formulations upon request. The D-Threo-Ritalinic Acid HCl suppliers may include D-Threo-Ritalinic Acid HCl API manufacturers, exporters, distributors and traders.
click here to find a list of D-Threo-Ritalinic Acid HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A D-Threo-Ritalinic Acid HCl DMF (Drug Master File) is a document detailing the whole manufacturing process of D-Threo-Ritalinic Acid HCl active pharmaceutical ingredient (API) in detail. Different forms of D-Threo-Ritalinic Acid HCl DMFs exist exist since differing nations have different regulations, such as D-Threo-Ritalinic Acid HCl USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A D-Threo-Ritalinic Acid HCl DMF submitted to regulatory agencies in the US is known as a USDMF. D-Threo-Ritalinic Acid HCl USDMF includes data on D-Threo-Ritalinic Acid HCl's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The D-Threo-Ritalinic Acid HCl USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of D-Threo-Ritalinic Acid HCl suppliers with USDMF on PharmaCompass.
D-Threo-Ritalinic Acid HCl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of D-Threo-Ritalinic Acid HCl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right D-Threo-Ritalinic Acid HCl GMP manufacturer or D-Threo-Ritalinic Acid HCl GMP API supplier for your needs.
A D-Threo-Ritalinic Acid HCl CoA (Certificate of Analysis) is a formal document that attests to D-Threo-Ritalinic Acid HCl's compliance with D-Threo-Ritalinic Acid HCl specifications and serves as a tool for batch-level quality control.
D-Threo-Ritalinic Acid HCl CoA mostly includes findings from lab analyses of a specific batch. For each D-Threo-Ritalinic Acid HCl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
D-Threo-Ritalinic Acid HCl may be tested according to a variety of international standards, such as European Pharmacopoeia (D-Threo-Ritalinic Acid HCl EP), D-Threo-Ritalinic Acid HCl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (D-Threo-Ritalinic Acid HCl USP).
